ResearcherOkayama University HospitalActive in the last 2 years
Ryota Chijimatsu
Matched on OpenAlex author ID A5015336755. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment respo… Co-author DOI 10.3892/ijo.2026.5849↗
- Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. Co-author DOI 10.1016/j.isci.2022.104659↗
- N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-15196-5↗
- Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer. Co-author DOI 10.18632/oncotarget.28035↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuichiro Doki · 3 shared papers, 2022–2026 · strength 0.49
- Paper Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as … DOI 10.3892/ijo.2026.5849↗
- Paper N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiother… DOI 10.1038/s41598-022-15196-5↗
- Paper Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. DOI 10.1016/j.isci.2022.104659↗
- Hidetoshi Eguchi · 3 shared papers, 2022–2026 · strength 0.49
- Paper Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as … DOI 10.3892/ijo.2026.5849↗
- Paper N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiother… DOI 10.1038/s41598-022-15196-5↗
- Paper Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. DOI 10.1016/j.isci.2022.104659↗
- Hideshi Ishii · 3 shared papers, 2021–2022 · strength 0.39
- Paper Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer. DOI 10.18632/oncotarget.28035↗
- Paper N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiother… DOI 10.1038/s41598-022-15196-5↗
- Paper Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. DOI 10.1016/j.isci.2022.104659↗
- Hirofumi Akita · 2 shared papers, 2022–2026 · strength 0.38
- Paper Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as … DOI 10.3892/ijo.2026.5849↗
- Paper N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiother… DOI 10.1038/s41598-022-15196-5↗
- Yoshito Tomimaru · 2 shared papers, 2022–2026 · strength 0.36
- Daisaku Yamada · 2 shared papers, 2022–2026 · strength 0.36
- Kazuhiko Ogawa · 2 shared papers, 2022 · strength 0.25
- Shotaro Tatekawa · 2 shared papers, 2022 · strength 0.25
- Tadafumi Asaoka · 1 shared paper, 2026 · strength 0.24
- Naoko Sekiguchi · 1 shared paper, 2026 · strength 0.24
- Yoshifumi Iwagami · 1 shared paper, 2026 · strength 0.24
- Shinichiro Hasegawa · 1 shared paper, 2026 · strength 0.24
- Ayumu Asai · 1 shared paper, 2021 · strength 0.14
- Suguru Mitsufuji · 1 shared paper, 2022 · strength 0.14
- Yoshiki Murakumo · 1 shared paper, 2022 · strength 0.14
- Yu Takeda · 1 shared paper, 2022 · strength 0.11
- Hidenori Takahashi · 1 shared paper, 2022 · strength 0.11
- Kazuki Sasaki · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.